Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Comparing COVID-19's stroke rate with those of other respiratory infections

The researchers compared hospitalized COVID-19 patients with influenza patients treated in 2018.

Scientists develop new protein that could limit damage during, and after, a stroke

The protein was designed to prevent cell death through the disruption of two specific Kv2.1 channels.

Thumbnail

How infection affects the health of acute ischemic stroke patients

The analysis, published in Stroke, gathered data from two massive patient registries in China. 

Thumbnail

How telemedicine could change the lives of stroke survivors

Approximately one in four stroke survivors are affected by disabling anxiety, but there are currently no specific guidelines in place to help these individuals. Could telemedicine be the answer? 

Thumbnail

Selatogrel provides heart attack patients with a lightning-fast antiplatelet response

A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.

Thumbnail

Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020. 

Thumbnail

A call to action: 5 ways to prevent venous thromboembolism in hospitalized patients

Venous thromboembolism is a common complication among hospitalized patients, one that leads to longer lengths of stay and costs health systems up to $10 billion annually.

Thumbnail

Blood thinners improve outcomes for hospitalized COVID-19 patients

Is it time to start routinely treating COVID-19 patients with anticoagulants?